First Time Loading...

Innovent Biologics Inc
HKEX:1801

Watchlist Manager
Innovent Biologics Inc Logo
Innovent Biologics Inc
HKEX:1801
Watchlist
Price: 40.4 HKD -3.46%
Updated: May 3, 2024

Innovent Biologics Inc
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Innovent Biologics Inc
Cash from Financing Activities Peer Comparison

Comparables:
6160
603392
S
002252
300122
300896

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Innovent Biologics Inc
HKEX:1801
Cash from Financing Activities
¥2.9B
CAGR 3-Years
-16%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Cash from Financing Activities
-¥448.1m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Cash from Financing Activities
-¥893.3m
CAGR 3-Years
N/A
CAGR 5-Years
-98%
CAGR 10-Years
N/A
S
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Cash from Financing Activities
-¥1.1B
CAGR 3-Years
-164%
CAGR 5-Years
1%
CAGR 10-Years
N/A
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Cash from Financing Activities
-¥2.4B
CAGR 3-Years
-5%
CAGR 5-Years
N/A
CAGR 10-Years
-39%
Imeik Technology Development Co Ltd
SZSE:300896
Cash from Financing Activities
-¥374.2m
CAGR 3-Years
-104%
CAGR 5-Years
-98%
CAGR 10-Years
N/A

See Also

What is Innovent Biologics Inc's Cash from Financing Activities?
Cash from Financing Activities
2.9B CNY

Based on the financial report for Dec 31, 2023, Innovent Biologics Inc's Cash from Financing Activities amounts to 2.9B CNY.

What is Innovent Biologics Inc's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
-8%

Over the last year, the Cash from Financing Activities growth was 1%. The average annual Cash from Financing Activities growth rates for Innovent Biologics Inc have been -16% over the past three years , -8% over the past five years .